PANCAIM – A European consortium to improve pancreatic cancer treatment with artificial intelligence optimizing, integrating genomics and medical imaging

European (EU) H2020 funded PANCAIM project, officially started on 1st January, 2021, will develop trusted impactful AI applications for regular clinical use to help clinical decision-makers to give the right treatment to the right patients at the right time, and at the right cost and improve treatment outcomes of PDAC patients.

Read the Press Release announcing the launch of the PANCAIM project.